Candece Gladson, M.D.

Affiliations: 
Cancer Biology Cleveland Clinic Lerner College of Medicine, Cleveland, OH, United States 
Area:
TNF-R1, FIP200, malignant gliomas
Website:
http://www.lerner.ccf.org/cancerbio/gladson/
Google:
"Candece Gladson"
Mean distance: 21373.2
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bae E, Huang P, Müller-Greven G, et al. (2022) Integrin α3β1 promotes vessel formation of glioblastoma-associated endothelial cells through calcium-mediated macropinocytosis and lysosomal exocytosis. Nature Communications. 13: 4268
Hashemi-Sadraei N, Müller-Greven GM, Abdul-Karim FW, et al. (2018) Expression of LC3B and FIP200/Atg17 in brain metastases of breast cancer. Journal of Neuro-Oncology
Muller-Greven G, Marin B, Carlin C, et al. (2018) CADD-57. THE EFFICACY OF THERAPY WITH ABT-414, AN EGFR-TARGETING ADC, IS POTENTIALLY ALTERED BY HETEROZYGOUS DELETION OF THE ENDOCYTIC TRAFFICKING REGULATOR RBSN Neuro-Oncology. 20: vi283-vi284
Müller-Greven GM, Carlin C, Burgett ME, et al. (2017) Macropinocytosis of Bevacizumab by Glioblastoma Cells in the Perivascular Niche Affects their Survival. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Ahluwalia MS, Bou-Anak S, Burgett ME, et al. (2016) Correlation of higher levels of soluble TNF-R1 with a shorter survival, independent of age, in recurrent glioblastoma. Journal of Neuro-Oncology
Burgett ME, Lathia JD, Roth P, et al. (2016) Direct contact with perivascular tumor cells enhances integrin αvβ3 signaling and migration of endothelial cells. Oncotarget
Burgett M, Nowacki A, Lathia J, et al. (2016) TMIC-27. CONTACT-INDUCED BI-DIRECTIONAL PRO-SURVIVAL SIGNALING BETWEEN ENDOTHELIAL CELLS AND CANCER STEM-LIKE CELLS IN GLIOBLASTOMA Neuro-Oncology. 18: vi205-vi206
Muller-Greven G, Carlin C, Toms S, et al. (2016) STMC-30. TRAFFICKING AND EFFECT ON SURVIVAL OF BEVACIZUMAB IN GLIOBLASTOMA Neuro-Oncology. 18: vi188-vi189
Muller-Greven G, Carlin C, Toms S, et al. (2015) STEM-12FATE OF BEVACIZUMAB IN GLIOBLASTOMA Neuro-Oncology. 17: v210.4-v210
Hale JS, Otvos B, Sinyuk M, et al. (2014) Cancer stem cell-specific scavenger receptor 36 drives glioblastoma progression. Stem Cells (Dayton, Ohio). 32: 1746-58
See more...